Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Technology Developed for Tissue Engineering

By LabMedica International staff writers
Posted on 05 Oct 2009
Researchers have received a U.S. More...
grant to develop a novel bioreactor system that will control the mechanoelectrochemical environment for tissue growth and also provide on-line monitoring for the properties of engineered tissues.

The two-year, US$735,000 grant from the U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH; Bethesda, MD, USA), will provide funding for the University of Miami (UM) College of Engineering (FL, USA). The grant will fund the work of Drs. Weiyong Gu and Charles Huang, professors in the department of biomedical engineering, to develop the novel bioreactor system for engineering tissue in vitro for implantation in vivo.

"Congratulations to Dr. Gu and Dr. Huang for being awarded such a prestigious grant on behalf of the College of Engineering,” stated Dean James M. Tien, Ph.D., NAE. "Funding from the NIH/NIBIB serves the college and university, and also opens lines of inquiry and exploration about how technology can be applied to reengineering the human body, a key focus of the College's research thrusts,” added Dr. Tien.

Tissue engineering research aims to develop functional substitutes for diseased or damaged tissues. In order to succeed, the mechanoelectrochemical environment in tissue culture needs to be optimized. "The new bioreactor system will provide innovative technology for tissue engineering, thus facilitating the development of functional replacement tissues that can be used in repairing damaged tissue, such as cartilage and intervertebral discs,” stated Dr. Huang.

There are two stages to the proposed project. The first stage will be to design and develop the bioreactor system and the second will evaluate the system. This technology will help scientists understand the mechanisms of tissue growth and tissue degeneration. "The broad, long-term objectives of the work are to elucidate the causes of intervertebral disc degeneration, to develop strategies for restoring tissue function or retarding further disc degeneration and to develop novel, less-invasive diagnostic tools for disc degeneration,” said Dr. Gu.

The grant provides an invaluable opportunity for undergraduate and graduate students in the College of Engineering to work hands-on with essential research and development in biomedical imaging and bioengineering, according to the researchers.

Related Links:
National Institute of Biomedical Imaging and Bioengineering
University of Miami College of Engineering



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.